264 related articles for article (PubMed ID: 24968134)
21. New renin inhibitor VTP-27999 alters renin immunoreactivity and does not unfold prorenin.
Krop M; Lu X; Verdonk K; Schalekamp MA; van Gool JM; McKeever BM; Gregg R; Danser AH
Hypertension; 2013 May; 61(5):1075-82. PubMed ID: 23460288
[TBL] [Abstract][Full Text] [Related]
22. Renoprotective effects of the direct renin inhibitor aliskiren on gentamicin-induced nephrotoxicity in rats.
Bae EH; Kim IJ; Joo SY; Kim EY; Choi JS; Kim CS; Ma SK; Lee J; Kim SW
J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):348-61. PubMed ID: 23420778
[TBL] [Abstract][Full Text] [Related]
23. Aliskiren reduces prorenin receptor expression and activity in cultured human aortic smooth muscle cells.
Ferri N; Greco CM; Maiocchi G; Corsini A
J Renin Angiotensin Aldosterone Syst; 2011 Dec; 12(4):469-74. PubMed ID: 21628356
[TBL] [Abstract][Full Text] [Related]
24. Anti-diabetic and renoprotective effects of aliskiren in streptozotocin-induced diabetic nephropathy in female rats.
Mahfoz AM; El-Latif HA; Ahmed LA; Hassanein NM; Shoka AA
Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1315-1324. PubMed ID: 27612855
[TBL] [Abstract][Full Text] [Related]
25. Aliskiren inhibits the renin-angiotensin system in retinal pigment epithelium cells.
Simão S; Santos DF; Silva GA
Eur J Pharm Sci; 2016 Sep; 92():22-7. PubMed ID: 27343695
[TBL] [Abstract][Full Text] [Related]
26. HRP and prorenin: focus on the (pro)renin receptor and vacuolar H+-ATPase.
Lu X; Danser AH; Meima ME
Front Biosci (Schol Ed); 2011 Jun; 3(4):1205-15. PubMed ID: 21622266
[TBL] [Abstract][Full Text] [Related]
27. Possible involvement of the (pro)renin receptor-dependent system in the development of insulin resistance.
Rafiq K; Hitomi H; Nakano D; Ichihara A; Nishiyama A
Front Biosci (Schol Ed); 2011 Jun; 3(4):1478-85. PubMed ID: 21622283
[TBL] [Abstract][Full Text] [Related]
28. Aliskiren increases bradykinin and tissue kallikrein mRNA levels in the heart.
Campbell DJ; Zhang Y; Kelly DJ; Gilbert RE; McCarthy DJ; Shi W; Smyth GK
Clin Exp Pharmacol Physiol; 2011 Sep; 38(9):623-31. PubMed ID: 21736602
[TBL] [Abstract][Full Text] [Related]
29. The direct renin inhibitor aliskiren improves vascular remodelling in transgenic rats harbouring human renin and angiotensinogen genes.
Savoia C; Arrabito E; Parente R; Sada L; Madaro L; Nicoletti C; Zezza L; Alonzo A; Rubattu S; Michelini S; Muller DN; Volpe M
Clin Sci (Lond); 2013 Aug; 125(4):183-9. PubMed ID: 23438195
[TBL] [Abstract][Full Text] [Related]
30. Aliskiren, at low doses, reduces the electrical remodeling in the heart of the TGR(mRen2)27 rat independently of blood pressure.
De Mello W; Rivera M; Rabell A; Gerena Y
J Renin Angiotensin Aldosterone Syst; 2013 Mar; 14(1):23-33. PubMed ID: 23118038
[TBL] [Abstract][Full Text] [Related]
31. Spironolactone enhances the beneficial effect of aliskiren on cardiac structural and electrical remodeling in TGR(mRen2)27 rats.
De Mello WC
J Renin Angiotensin Aldosterone Syst; 2015 Sep; 16(3):488-94. PubMed ID: 24036520
[TBL] [Abstract][Full Text] [Related]
32. FT011, a Novel Cardiorenal Protective Drug, Reduces Inflammation, Gliosis and Vascular Injury in Rats with Diabetic Retinopathy.
Deliyanti D; Zhang Y; Khong F; Berka DR; Stapleton DI; Kelly DJ; Wilkinson-Berka JL
PLoS One; 2015; 10(7):e0134392. PubMed ID: 26222724
[TBL] [Abstract][Full Text] [Related]
33. Renin inhibition ameliorates renal damage through prominent suppression of both angiotensin I and II in human renin angiotensinogen transgenic mice with high salt loading.
Yoshida S; Ishizawa K; Ayuzawa N; Ueda K; Takeuchi M; Kawarazaki W; Fujita T; Nagase M
Clin Exp Nephrol; 2014 Aug; 18(4):593-9. PubMed ID: 24154707
[TBL] [Abstract][Full Text] [Related]
34. [Role of (pro)renin receptor in diabetic retinopathy].
Satofuka S
Nippon Ganka Gakkai Zasshi; 2011 Nov; 115(11):1015-24. PubMed ID: 22171507
[TBL] [Abstract][Full Text] [Related]
35. Aliskiren restores renal AQP2 expression during unilateral ureteral obstruction by inhibiting the inflammasome.
Wang W; Luo R; Lin Y; Wang F; Zheng P; Levi M; Yang T; Li C
Am J Physiol Renal Physiol; 2015 Apr; 308(8):F910-22. PubMed ID: 25694485
[TBL] [Abstract][Full Text] [Related]
36. [(Pro) renin receptor in the pathogenesis of proliferative diabetic retinopathy].
Kanda A
Nippon Ganka Gakkai Zasshi; 2014 Nov; 118(11):916-26. PubMed ID: 25543383
[TBL] [Abstract][Full Text] [Related]
37. Direct renin inhibition in a rat model of chronic allograft injury.
Rusai K; Schmaderer C; Hermans JJ; Lutz J; Heemann U; Baumann M
Transplantation; 2011 Nov; 92(9):999-1004. PubMed ID: 21956196
[TBL] [Abstract][Full Text] [Related]
38. (Pro)renin Receptor Blockade Ameliorates Heart Failure Caused by Chronic Kidney Disease.
Yoshida A; Kanamori H; Naruse G; Minatoguchi S; Iwasa M; Yamada Y; Mikami A; Kawasaki M; Nishigaki K; Minatoguchi S
J Card Fail; 2019 Apr; 25(4):286-300. PubMed ID: 30769036
[TBL] [Abstract][Full Text] [Related]
39. Pathologic Roles of Receptor-Associated Prorenin System in Idiopathic Epiretinal Membrane.
Dong Y; Kanda A; Noda K; Saito W; Ishida S
Sci Rep; 2017 Mar; 7():44266. PubMed ID: 28276504
[TBL] [Abstract][Full Text] [Related]
40. Aliskiren accumulation in the kidney: no major role for binding to renin or prorenin.
Lange S; Fraune C; Alenina N; Bader M; Danser AH; Frenay AR; van Goor H; Stahl R; Nguyen G; Schwedhelm E; Wenzel UO
J Hypertens; 2013 Apr; 31(4):713-9. PubMed ID: 23407438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
